Clinical trials

Clinical trials

Participation of women in clinical trials of drug therapies: a context for the controversies

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Marianne N. Prout, MD, MPH
Susan S. Fish, PharmD, MPH
Edition: 
Volume 3, Number 4
Publisher: 
Medscape General Medicine
Publication Date: 
2001

Set of six articles, written from an American perspective, introducing the issue of women’s exclusion from clinical drug trials. Examines how and why women have historically been under-represented in or excluded from drug trials, and the negative effects this has had on women’s health care. Asks whether women have yet achieved adequate access to clinical research. (Requires free registration in Medscape to access.)

Available From: 
Order Information: 
Available online.
Notes: 
Includes bibliographical references.

Understanding clinical trials

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Publisher: 
U.S. National Institutes of Health
Publication Date: 
2007

Provides a plain language overview of the clinical trial process and the different kinds of trials for those interested in participating in clinical trials, as well as anyone wanting to learn how they are conducted.

Available From: 
Order Information: 
Available online.

Moving toward assured access to treatment in microbicide trials

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Anna Forbes
Publisher: 
PLoS Medicine
Publication Date: 
2006
Publication Place: 
San Francisco, CA

Looks at the ethical questions surrounding microbicide research, particularly care issues for people in resource-poor countries who sero-convert during clinical trials.

Available From: 
ISBN/ISSN: 
ISSN 15491277 (Print)
ISSN 15491676 (Electronic)
Notes: 
Includes bibliographical references.

The inclusion of women in clinical trials: are we asking the right questions?

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Abby Lippman
Publisher: 
Women and Health Protection
Publication Date: 
2006
Publication Place: 
Toronto, ON

Addresses the issues evoked in considering the inclusion of women in clinical trials, highlighting especially where gender, even more than sex, is pertinent.

Available From: 
ISBN/ISSN: 
ISBN 0973870184
WHP PHAR.L57 2006
Notes: 
Includes bibliographical references.

Cholinesterase inhibitors: drugs looking for a disease?

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Marina Maggini
Nicola Vanacore
Roberto Raschetti
Publisher: 
PLoS Medicine
Publication Date: 
2006
Publication Place: 
San Francisco, CA

Discusses the use of cholinesterase inhibitors in patients with a variety of types of dementia and cognitive impairment, looking critically at the clinical trial evidence on these drugs.

Available From: 
ISBN/ISSN: 
ISSN 15491277 (print)
ISSN 15491676 (online)
Notes: 
Includes bibliographical references.

Enrolling women into HIV prevention vaccine trials: an ethical imperative but a logistical challenge

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Edward Mills
Stephanie Nixon
Sonal Singh
Sonam Dolma
Anjali Nayyar
Sushma Kapoor
Publisher: 
PLoS Medicine
Publication Date: 
2006
Publication Place: 
San Francisco, CA

Reviews women's concerns about enrolling in HIV vaccine trials, fears of adverse events, issues of informed consent, barriers faced by sex workers, benefits of participation, and the role of researchers as human rights advocates.

Available From: 
ISBN/ISSN: 
ISSN 15491277 (Print)
ISSN 15491676 (Online)
Notes: 
Includes bibliographical references.

When clinical trials are compromised: a perspective from a patient advocate

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Musa Mayer
Publisher: 
PLoS Medicine
Publication Date: 
2005
Publication Place: 
San Francisco, CA

Examines how the rush to approve experimental treatments before appropriate clinical trials can lead to increased suffering and death.

Available From: 
ISBN/ISSN: 
ISSN 15491277 (print)
ISSN 15491676 (Online)
Notes: 
Includes bibliographical references.

Canadian HIV Trials Network

Text Size: Normal / Medium / Large
Organization Type: 
NGO - Non Government Organization
Service Language: 
English
Français
Services Provided: 
Research

Promotes the development of treatments, vaccines and a cure for HIV/AIDS through the conduct of scientifically sound and ethical clinical trials. Website provides information about clinical trials in Canada, including a clinical trials database.

Primary Telephone: 
604-806-8327
Website/URL: 
Email Address: 
ctn@hivnet.ubc.ca
Fax Number: 
604-806-8210
Tollfree Phone Number: 
800-661-4664
Street Address: 
620B-1081 Burrard St
City: 
Vancouver
Province: 
British Columbia
Postal/ZIP Code: 
V6Z 1Y6

Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of effica

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Howard M. Schachter
Tammy J. Clifford
Ann Cranney
Nicholas J. Barrowman
David Moher
Publisher: 
Technology Report
Publication Date: 
2005
Publication Place: 
Ottawa, ON

Evaluates the safety and efficacy of raloxifene compared with placebo and other drugs approved in Canada for the primary and secondary prevention of osteoporotic vertebral fractures in postmenopausal women.

ISBN/ISSN: 
ISBN 1894978218 (Print)
ISBN 1894978226 (Online)
Notes: 
Includes bibliographical references.

Practical and ethical dilemmas in the clinical testing of microbicides: a report on a symposium

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Lori L. Heise
C. Elizabeth McGrory
Susan Y. Wood
Publisher: 
International Women's Health Coalition
Publication Date: 
1998
Publication Place: 
New York, NY

Describes microbicides, substances that would reduce the transmission of sexually transmitted infections (STIs) when used vaginally or rectally. Summarizes extensive deliberations, key decisions and recommendations made at a 1997 symposium of 55 advocates, scientists, policy makers, and industry representatives from 15 countries across Africa, Asia, Latin America, Europe, and the United States. Addresses such complex issues as informed consent, standard of care, community participation, the role of social science, and implications for public policy.

ISBN/ISSN: 
WOMH.H45 1998
Syndicate content